At Obsidian, we are pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases

Obsidian’s cytoDRiVE™ technology provides a way to regulate protein levels delivered by cell and gene therapies using FDA-approved small molecule drugs